width=Because more than 25% of patients with ataxia-telangiectasia (A-T) develop some form of chronic lung disease, the A-T Children’s Project has awarded a fellowship grant to Abrey Yeo, PhD in Australia to examine the mixture of bacteria found in the airways of individuals with A-T.

Even healthy people have numerous types of bacteria in their lungs, but Dr. Yeo is interested in identifying imbalances between the types of bacteria in the lungs of patients with A-T that may predispose them to problems. In particular, because not having a functioning A-T protein makes the cells of people with A-T more vulnerable to oxidative stress caused by free radicals, Dr. Yeo will determine whether the lung bacteria in A-T-related lung disease generate excessive free radicals.

Working in Professor Martin Lavin’s laboratory at the University of Queensland, Dr. Yeo’s unique approach may reveal specific bacteria populations that are responsible for lung problems in A-T and suggest treatment approaches to help people with A-T live longer, healthier lives.

Oops! We could not locate your form.

Related News

Apr 11 @ 10:47 pm

Lost Cleveland Memories’ 500th Presentation for the A-TCP!

Dennis has turned his love of history and storytelling into Lost Cleveland Memories, an incredibly successful fundraising effort

more
Apr 11 @ 10:47 pm

Race with the A-T CureTeam at Disney!

Announcing the CureTeam's Walt Disney World race schedule!

more
Apr 11 @ 10:47 pm

Disappointing Results from Quince’s Clinical Trial of eDSP in A-T

Quince Therapeutics reports topline results from their Phase 3 “NEAT” trial in A-T.

more
Apr 11 @ 10:47 pm

Press Release about Intrabio’s A-T Trial Results

IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.

more